Skip to main content
Premium Trial:

Request an Annual Quote

Dennis Langer, Kreatech, Ambion, GE Healthcare, Affymetrix


People in the News

Sirna Therapeutics said this week that Dennis Langer has been appointed to its board of directors.

Langer is currently managing partner at Phoenix IP Ventures, a Philadelphia-based venture capital firm. Prior to this position, he was president, North America, at Indian drugs firm Dr Reddy's Laboratories. Langer has also held positions at GlaxoSmithKline, SmithKline Beecham, and Eli Lilly.

Langer holds an MD from Georgetown University, a JD from Harvard Law School, and a BA in biology from Columbia University, Sirna said.


Products & Services

Kreatech said this week that it has introduced RNA Ampulse Amplification and labeling kits for gene expression analysis.

According to the company, the kits combine Ambion's MessageAmp II aRNA amplification system technology with Kreatech's Universal Linkage system labeling technology.

The kits offer the ULS labeling molecule bound to a choice of fluorescent dye pairs that have been licensed by Kreatech, including the dyes from GE Healthcare, as well as a biotin kit which is ideal for use on Affymetrix's GeneChip, Kreatech said. In addition the RNA Ampulse kit also includes Kreatech's unique Kreapure columns to purify the labeled aRNA which insures effective removal of un-reacted ULS and higher recoveries of sample, the company added.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.